Friday, March 29, 2024
Home Tags Pharmaceuticals

Tag: pharmaceuticals

Reneo Pharmaceuticals Announces Pricing of Initial Public Offering

0
SAN DIEGO, April 08, 2021 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and...

ViaDerma, Inc. Provides Preliminary Revenue Estimates and Highlights for its Record...

0
LOS ANGELES, April 08, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), is pleased to provide an update of...

Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock

0
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical-stage pharmaceutical company focused on the discovery,...

Amphastar Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare...

0
RANCHO CUCAMONGA, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan...

Eloxx Pharmaceuticals Acquires Zikani Therapeutics

0
Combined Company to be Leader in Ribosomal RNA-Targeted Genetic Therapy Bringing Together Complementary Platforms Maximizes Potential for ELX-02 for Cystic Fibrosis in...

Flow Chemistry Market Size To Reach USD 3.27 Billion in 2028;...

0
New York, March 29, 2021 (GLOBE NEWSWIRE) -- Increasing adoption of flow chemistry in pharmaceutical, chemicals, and petrochemicals industries is key...

Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results...

0
Announced updated STS101 development plan featuring a new Phase 3 efficacy trial scheduled to begin enrollment mid-2021 with topline results expected in second...

DIAMOND Mouse Model is Latest in a String of Nonclinical Studies...

0
EDISON, N.J., March 23, 2021 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA, “Hepion”), a clinical stage biopharmaceutical company focused on Artificial...

Rhythm Pharmaceuticals Presents New Data from Phase 2 Basket Study Showing...

0
-- Responders with HET obesity achieved mean weight loss of greater than 12 percent at nine months on setmelanotide therapy -- --...

Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab...

0
EXTON, Pa., March 18, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA; the “Company”) today is announcing that ILLUMINATE-301, the...

Press Realease

Business News

Cricket

Weather News

Lifestyle

World News

UK / USA News

Local News